200 related articles for article (PubMed ID: 23102762)
21. Evaluation of recombinant proteins of Neospora caninum as vaccine candidates (in a mouse model).
Ellis J; Miller C; Quinn H; Ryce C; Reichel MP
Vaccine; 2008 Nov; 26(47):5989-96. PubMed ID: 18789996
[TBL] [Abstract][Full Text] [Related]
22. Neospora caninum antigens defined by antigen-dependent bovine CD4+ T cells.
Tuo W; Fetterer RH; Davis WC; Jenkins MC; Dubey JP
J Parasitol; 2005 Jun; 91(3):564-8. PubMed ID: 16108548
[TBL] [Abstract][Full Text] [Related]
23. [Advances in the development of vaccines for bovine neosporosis].
Hecker YP; Venturini MC; Campero CM; Odeón AC; Moore DP
Rev Argent Microbiol; 2012; 44(3):216-30. PubMed ID: 23102471
[TBL] [Abstract][Full Text] [Related]
24. An applied printing immunoassay with recombinant Nc-SAG1 for detection of antibodies to Neospora caninum in cattle.
Wilkowsky SE; Bareiro GG; Mon ML; Moore DP; Caspe G; Campero C; Fort M; Romano MI
J Vet Diagn Invest; 2011 Sep; 23(5):971-6. PubMed ID: 21908357
[TBL] [Abstract][Full Text] [Related]
25. Identification of vaccine candidate peptides in the NcSRS2 surface protein of Neospora caninum by using CD4+ cytotoxic T lymphocytes and gamma interferon-secreting T lymphocytes of infected holstein cattle.
Staska LM; Davies CJ; Brown WC; McGuire TC; Suarez CE; Park JY; Mathison BA; Abbott JR; Baszler TV
Infect Immun; 2005 Mar; 73(3):1321-9. PubMed ID: 15731029
[TBL] [Abstract][Full Text] [Related]
26. Development of a diagnostic method for neosporosis in cattle using recombinant Neospora caninum proteins.
Dong J; Otsuki T; Kato T; Park EY
BMC Biotechnol; 2012 May; 12():19. PubMed ID: 22558916
[TBL] [Abstract][Full Text] [Related]
27. RecNcMIC3-1-R is a microneme- and rhoptry-based chimeric antigen that protects against acute neosporosis and limits cerebral parasite load in the mouse model for Neospora caninum infection.
Monney T; Rütti D; Schorer M; Debache K; Grandgirard D; Leib SL; Hemphill A
Vaccine; 2011 Sep; 29(40):6967-75. PubMed ID: 21787824
[TBL] [Abstract][Full Text] [Related]
28. Immunization of mice with plasmid DNA coding for NcGRA7 or NcsHSP33 confers partial protection against vertical transmission of Neospora caninum.
Liddell S; Parker C; Vinyard B; Jenkins M; Dubey JP
J Parasitol; 2003 Jun; 89(3):496-500. PubMed ID: 12880248
[TBL] [Abstract][Full Text] [Related]
29. Delivery of Neospora caninum surface protein, NcSRS2 (Nc-p43), to mouse using recombinant vaccinia virus.
Nishikawa Y; Kousaka Y; Fukumoto S; Xuan X; Nagasawa H; Igarashi I; Fujisaki K; Otsuka H; Mikami T
Parasitol Res; 2000 Nov; 86(11):934-9. PubMed ID: 11097303
[TBL] [Abstract][Full Text] [Related]
30. Development of latex agglutination test with recombinant NcSAG1 for the rapid detection of antibodies to Neospora caninum in cattle.
Moraveji M; Hosseini A; Moghaddar N; Namavari MM; Eskandari MH
Vet Parasitol; 2012 Oct; 189(2-4):211-7. PubMed ID: 22571832
[TBL] [Abstract][Full Text] [Related]
31. Constitutive expression and characterization of a surface SRS (NcSRS67) protein of Neospora caninum with no orthologue in Toxoplasma gondii.
Bezerra MA; Pereira LM; Bononi A; Biella CA; Baroni L; Pollo-Oliveira L; Yatsuda AP
Parasitol Int; 2017 Apr; 66(2):173-180. PubMed ID: 28108401
[TBL] [Abstract][Full Text] [Related]
32. Towards a preventive strategy for neosporosis: challenges and future perspectives for vaccine development against infection with Neospora caninum.
Nishikawa Y
J Vet Med Sci; 2017 Aug; 79(8):1374-1380. PubMed ID: 28690279
[TBL] [Abstract][Full Text] [Related]
33. Low efficacy of NcGRA7, NcSAG4, NcBSR4 and NcSRS9 formulated in poly-ε-caprolactone against Neospora caninum infection in mice.
Jiménez-Ruiz E; Alvarez-García G; Aguado-Martínez A; Salman H; Irache JM; Marugán-Hernández V; Ortega-Mora LM
Vaccine; 2012 Jul; 30(33):4983-92. PubMed ID: 22640942
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-12 response to NcSRS2 immunization of BALB/c mice against Neospora caninum.
Gonçalves KN; Andreotti R; Paiva F; Pontes ER; Lima Junior MS; Matos LM
Rev Bras Parasitol Vet; 2008 Sep; 17 Suppl 1():215-9. PubMed ID: 20059851
[TBL] [Abstract][Full Text] [Related]
35. Identification of suitable adjuvant for vaccine formulation with the Neospora caninum antigen NcSRS2.
Pinheiro AF; Roloff BC; da Silveira Moreira A; Berne MEA; Silva RA; Leite FPL
Vaccine; 2018 Feb; 36(9):1154-1159. PubMed ID: 29395519
[TBL] [Abstract][Full Text] [Related]
36. Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant.
Cannas A; Naguleswaran A; Müller N; Gottstein B; Hemphill A
J Parasitol; 2003 Feb; 89(1):44-50. PubMed ID: 12659301
[TBL] [Abstract][Full Text] [Related]
37. Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines.
Cannas A; Naguleswaran A; Müller N; Eperon S; Gottstein B; Hemphill A
Parasitology; 2003 Apr; 126(Pt 4):303-12. PubMed ID: 12741509
[TBL] [Abstract][Full Text] [Related]
38. Comparative efficacy of immunization with inactivated whole tachyzoites versus a tachyzoite-bradyzoite mixture against neosporosis in mice.
Rojo-Montejo S; Collantes-Fernández E; Rodríguez-Marcos S; Pérez-Zaballos F; López-Pérez I; Prenafeta A; Ortega-Mora LM
Parasitology; 2011 Sep; 138(11):1372-83. PubMed ID: 21810300
[TBL] [Abstract][Full Text] [Related]
39. Immunization of dogs with a canine herpesvirus vector expressing Neospora caninum surface protein, NcSRS2.
Nishikawa Y; Ikeda H; Fukumoto S; Xuan X; Nagasawa H; Otsuka H; Mikami T
Int J Parasitol; 2000 Oct; 30(11):1167-71. PubMed ID: 11027782
[TBL] [Abstract][Full Text] [Related]
40. Transgenic Neospora caninum strains constitutively expressing the bradyzoite NcSAG4 protein proved to be safe and conferred significant levels of protection against vertical transmission when used as live vaccines in mice.
Marugán-Hernández V; Ortega-Mora LM; Aguado-Martínez A; Jiménez-Ruíz E; Alvarez-García G
Vaccine; 2011 Oct; 29(44):7867-74. PubMed ID: 21816191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
